IFN-γ, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis

Journal of Infection

Volumn 61, Issue 2, 2010, Pages 133-143

  Goletti, Delia ^a   Raja, Alamelu ^b   Ahamed Kabeer, Basirudeen Syed ^b   Rodrigues, Camilla ^c   Sodha, Archana ^c   Butera, Ornella ^a   Carrara, Stefania ^a   Vernet, Guy ^d   Longuet, Christophe ^d   Ippolito, Giuseppe ^a   Thangaraj, Satheesh ^e   Leportier, Marc ^e   Girardi, Enrico ^a   Lagrange, Philippe Henri ^f  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b Tuberculosis Research Centre ICMR   (India)

^c P D HINDUJA NATIONAL HOSPITAL   (India)

^d Scientific Direction   (France)

^e BIOMÉRIEUX   (France)

^f SAINT LOUIS HOSPITAL   (France)

Author keywords

IGRA; IL 2; IP 10; LTBI; MCP 2; RD1 peptides; Tuberculosis

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 2; MONOCYTE CHEMOTACTIC PROTEIN 2; BACTERIAL ANTIGEN; CCL8 PROTEIN, HUMAN; CXCL10 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; EVALUATION STUDY; IMMUNOASSAY; IMMUNOLOGY; MIDDLE AGED; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; CHEMOKINE CCL8; CHEMOKINE CXCL10; FEMALE; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; INTERLEUKIN-2; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 77955054269     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.05.002     Document Type: Article

References (34)

1. Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149:177-184.
2. Lalvani A., Pathan A.A., Durkan H., Wilkinson K.A., Whelan A., Deeks J.J., et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001, 357:2017-2021.
3. Mori T., Sakatani M., Yamagishi F., Takashima T., Kawabe Y., Nagao K., et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004, 170:59-64.
4. Ewer K., Deeks J., Alvarez L., Bryant G., Waller S., Andersen P., et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003, 361:1168-1173.
5. Vincenti D., Carrara S., De Mori P., Pucillo L.P., Petrosillo N., Palmieri F., et al. Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis. Mol Med 2003, 9:105-111.
6. Goletti D., Vincenti D., Carrara S., Butera O., Bizzoni F., Bernardini G., et al. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol 2005, 12:1311-1316.
7. Carrara S., Vincenti D., Petrosillo N., Amicosante M., Girardi E., Goletti D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 2004, 38:754-756.
8. Goletti D., Butera O., Bizzoni F., Casetti R., Girardi E., Poccia F. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis 2006, 194:984-992.
9. Goletti D., Carrara S., Butera O., Amicosante M., Ernst M., Sauzullo I., et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-study. PLoS ONE 2008, 3:e3417.
10. Goletti D., Carrara S., Mayanja-Kizza H., Baseke J., Mugerwa M.A., Girardi E., et al. Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study. BMC Infect Dis 2008, e28:11.
11. Goletti D., Parracino M.P., Butera O., Bizzoni F., Casetti R., Dainotto D., et al. Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respir Res 2007, 8:5.
12. Ministero della Salute http://www.ministerosalute.it/promozione/malattie/bollettino.jsp.
13. Leyten E.M., Lin M.Y., Franken K.L., Friggen A.H., Prins C., van Meijgaarden K.E., et al. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect 2006, 8:2052-2060.
14. Goletti D., Butera O., Vanini V., Lauria F.N., Lange C., Franken K.L., et al. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur Respir J 2010, 36:1-8.
15. Leyten E.M., Arend S.M., Prins C., Cobelens F.G., Ottenhoff T.H., van Dissel J.T. Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol 2007, 14:880-885.
16. Lawn S.D., Bangani N., Vogt M., Bekker L.G., Badri M., Ntobongwana M., et al. Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis 2007, 7:99.
17. Butera O., Chiacchio T., Carrara S., Casetti R., Vanini V., Meraviglia S., et al. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect Dis 2009, 9:182.
18. Millington K.A., Innes J.A., Hackforth S., Hinks T.S., Deeks J.J., Dosanjh D.P., et al. Dynamic relationship between IFN-γ and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 2007, 178:5217-5226.
19. Biselli R, Mariotti S, Sargentini V, Sauzullo I, Lastilla M, Mengoni F, et al. Detection of IL-2 in addition to IFN-gamma discriminates active tuberculosis patients, latently infected individuals and controls. Clin Microbiol Infect, in press, doi:10.1111/j.1469-0691.2009.03104.x.
20. Sargentini V., Mariotti S., Carrara S., Gagliardi M.C., Teloni R., Goletti D., et al. Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis 2009, 9:99.
21. Ruhwald M., Bjerregaard-Andersen M., Rabna P., Kofoed K., Eugen-Olsen J., Ravn P. CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect 2007, 9:806-812.
22. Ruhwald M., Bodmer T., Maier C., Jepsen M., Haaland M.B., Eugen-Olsen J., Ravn P., Tbnet Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 2008, 32:1607-1615.
23. Petrucci R., Abu Amer N., Gurgel R.Q., Sherchand J.B., Doria L., Lama C., et al. Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatr Infect Dis J 2008, 27:1073-1077.
24. Ruhwald M., Petersen J., Kofoed K., Nakaoka H., Cuevas L.E., Lawson L., et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One 2008, 6(3):e2858.
25. Whittaker E., Gordon A., Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?. PLoS One 2008, 3:e3901.
26. Moser B., Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001, 2:123-128.
27. Korpi-Steiner N.L., Bates M.E., Lee W.M., Hall D.J., Bertics P.J. Human rhinovirus induces robust IP-10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and STAT1 activation. J Leukoc Biol 2006, 80:1364-1374.
28. Mezger M., Steffens M., Beyer M., Manger C., Eberle J., Toliat M.R., et al. Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem cell transplantation and influence CXCL10 expression in monocyte-derived dendritic cells. Blood 2008, 111:534-536.
29. Azzurri A., Sow O.Y., Amedei A., Bah B., Diallo S., Peri G., et al. IFN-γ-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 2005, 7:1-8.
30. Okamoto M., Kawabe T., Iwasaki Y., Hara T., Hashimoto N., Imaizumi K., et al. Evaluation of interferon-γ, interferon-γ-inducing cytokines, and interferon-γ-inducible chemokines in tuberculous pleural effusions. J Lab Clin Med 2005, 145:88-93.
31. Berktas M., Guducuoglu H., Bozkurt H., Onbasi K.T., Kurtoglu M.G., Andic S. Change in serum concentrations of interleukin-2 and interferon-gamma during treatment of tuberculosis. J Int Med Res 2004, 32:324-330.
32. Central TB Division, Directorate general of health services, ministry of health and family welfare Revised National Tuberculosis Control Programme manual for laboratory technicians 2008, Ministry of Health and Family Welfare, New Delhi, India. http://www.tbcindia.org/LABMANUAL.pdf.
33. Chadha V.K., Jagannatha P.S., Vaidyanathan P.S., Jagota P. PPD RT23 for tuberculin surveys in India. Int J Tuberc Lung Dis 2003, 7:172-179.
34. Pai M., Joshi R., Dogra S., Zwerling A.A., Gajalakshmi D., Goswami K., et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 2009, 13:84-92.